3 Small-Cap Stocks Set To Skyrocket
These under-the-radar companies may offer greater long-term rewards.
Why Ardelyx Stock Soared Today
Ardelyx delivered a strong quarter thanks to solid demand for its first FDA-approved product. Here's what investors need to know.
Why Ardelyx Stock Popped Today
Ardelyx finally received the long-awaited FDA approval for its chronic kidney disease drug.
Why Shares of Ardelyx Were Down Wednesday
The company's hopes for approval of a drug to treat chronic kidney disease took a hit.
Markets Today: Stock Indexes Push Higher Ahead of Fed Chair Powell’s Speech
Morning Markets September E-Mini S&P 500 futures (ESU2 3) this morning are up +0.27%, and Sep Nasdaq 100 E-Mini futures (NQU2 3) are up +0.12%. Stock indexes this morning are moderately higher on mild...